A catheter is a thin tube medical device made from superior graded material sourced in the healthcare sector to distribute gases, medications, or fluids to patients or remove bodily fluids such as Urine. According to BlueQuark the Global Catheters Market is expected to grow considerably during the forecasted period. Factors such as the increase in the usage of urological catheters due to the rise in the prevalence of end-stage renal diseases, kidney problems, and urinary tract infections are expected to drive the catheter market in the forecasted period. Further, growth in demand for angioplasty over conventional surgeries, owing to its minimally invasive nature, is expected to drive the Catheters Market in the forecasted period. Furthermore, an increase in patients with cardiac disorders, while technological advancements for better treatment are expected to drive the Catheters Market in the forecasted period. However, due to the increase in the number of entrants in the market, the quality of catheter devices deteriorates. These manufacturers use cheap and substandard raw materials to manufacture the product at low prices, restricting market growth.

The urological catheter segment is expected to grow considerably during the forecast period. A urinary catheter is found to be necessary for a person facing difficulty passing Urine naturally. The segment is expected to show high growth during the forecasted period owing to growing incidences of urological disorders, as these products are used for patients who suffer from urological disorders. Kidney disease is responsible for stroke, heart attack, kidney failure, and attack. Catheters are thin nylon tubes, plastic, polyvinyl chloride (PVC), and silicon rubber. It is broadly used in catheterization during surgical procedures like neurosurgery and angioplasty. This market is growing significantly due to a surge in the population that suffers from cardiovascular disorders and diabetes. Presently, many countries have shown an increase in the number of patients suffering from hypertension and diabetes due to a sedentary lifestyle along with a growing drinking and smoking population.

Moreover, favourable reimbursement policies are growing the demand for minimally invasive surgeries, and the use of catheters is also advancing technologically with high effectiveness. All these factors will eventually drive the catheter market. Catheters are used in surgeries like angioplasty, pushing the market to grow. There is also the reimbursement policy by the Medicaid program, which offers around 100 catheters every 100 months due to the growing prevalence of cardiovascular disease and the growing demand for minimally invasive surgeries. Also, there is an increase in chronic disease cases related to kidney failures, urinary bladder, etc. All these factors would eventually drive the catheter market in the forecasting period. There is an increase in the demand for angioplasty compared to conventional surgeries as it is minimally invasive. All these factors are propelling the growth of the catheter market. The growing prevalence of urinary incontinence and an increasing number of surgical procedures are the vital factors driving the demand for urinary catheters, boosting the segment's growth.

The North American region is expected to hold a significant market share in the catheters market during the forecast period. The United States is expected to dominate the market due to government support for medical devices and an increasing number of surgeries. Minimally invasive techniques require using catheters for procedures such as angioplasty, stenting, ablation, and endovascular interventions. Catheters play a crucial role in various minimally invasive procedures. They're slender, flexible tubes inserted in your body via tiny incisions or regular orifices. With catheters, access to target areas within the body allows for diagnosis and treatment. However, they can be used for various purposes, such as delivering medication or contrast agents, draining fluids, removing blockages, measuring pressure, or obtaining tissue samples. Increasing demand for catheters will be supplemented by an increase in surgeons and patients seeking fewer invasive treatments than conventional surgical interventions, which is expected to propel market growth over the forecasted period. Chronic diseases such as cardiovascular diseases, diabetes, urinary disorders, and kidney disease are on the rise globally. Using catheters is an essential part of managing and treating these conditions, which drives the need for catheters. The world's population is ageing, with older people increasingly requiring more medical treatment and procedures.

Hospital stores are situated on the hospital premises, dispensing a wide range of catheters required for surgical and minimally invasive procedures. Unlike regular pharmacies catering to outpatients, hospital stores prioritize the needs of patients admitted to the hospital. These cater to specific and often rare medical conditions, requiring precise storage and handling protocols. Additionally, modern hospital stores leverage cutting-edge technology to streamline operations and optimize medication management. Automated dispensing systems, electronic prescribing platforms, and advanced inventory tracking software are just a few examples. These technologies minimize errors, improve efficiency, and enhance patient care. Time is often of the essence in healthcare, and hospital stores ensure immediate access to the needed catheters. This reduces delays in treatment and potentially improves patient outcomes. These factors boost the demand for catheters in the hospital stores, driving the market growth.

The market key players are Hollister Incorporated, Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, and Smith Medical Inc.

In August 2023, Boston Scientific Corporation received the FDA clearance for the POLARx Cryoablation System. This system is designed to treat patients having paroxysmal atrial fibrillation (AF). This system has POLARx FIT Cryoablation Balloon Catheter, an instrument with the impressive capability of facilitating two balloon measures, 28mm and 33mm, in a single catheter, which is helpful in the minimally invasive cryoablation procedure. It will eventually help the organization gain market share in the catheter market.

In October 2023, the Orchid SRV safety-released valves were approved by the U.S. FDA, according to Linear Health Sciences. The purpose of the catheter, which had been authorized to be employed with all IV access procedures, was to reduce the likelihood of IV catheter rupture and repair in hospitals.

Global Catheters Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Catheters Market by segmenting based on Product Type (Cardiovascular Catheters, Neurovascular Catheters, Urological Catheters, Intravenous Catheters, and Specialty Catheters), End-User Industry (Hospitals, Ambulatory Surgery Centers, Dialysis Centers, and Others), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East & Africa). The report examines the market drivers and restraints and the impact of COVID-19 on market growth in detail. The study covers emerging market trends, development, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.